TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07195591: Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Sponsor: GT Medical Technologies, Inc. · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 766 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$20,993,280

Rescue Site Savings

+$13,842,444

Unlock Full NCT07195591 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07195591 Rescue Dossier →